Suchergebnisse - "Fujii, Naohiko"

PubPharm (8)

1

Serum phosphate levels modify the impact of parathyroid hormone levels on renal outcomes in kidney transplant recipients

enthalten in: Scientific reports | 2020

von Doi, Y. | Hamano, T. | Ichimaru, N. | +14

2

Clinical features of CKD-MBD in Japan : cohort studies and registry

enthalten in: Clinical and experimental nephrology | 2017

von Hamano, T. | Sakaguchi, Y. | Fujii, N. | +1

3

Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation

enthalten in: Bone | 2012

von Tomida, K. | Hamano, T. | Ichimaru, N. | +7

4

Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis

enthalten in: Bone | 2012

von Nakano, C. | Hamano, T. | Fujii, N. | +11

CommentIn: Bone. 2012 Oct;51(4):830-1; author reply 832-3. - PMID 22683387

5

Combined use of vitamin D status and FGF23 for risk stratification of renal outcome

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2012

von Nakano, C. | Hamano, T. | Fujii, N. | +9

6

CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). CKD-MBD in CKD patients not yet on dialysis; Status Quo

enthalten in: Clinical calcium | 2010

von Fujii, N.

7

The impact of diabetes mellitus on vitamin D metabolism in predialysis patients

enthalten in: Bone | 2009

von Tanaka, H. | Hamano, T. | Fujii, N. | +10

8

Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients

enthalten in: Bone | 2009

von Tomida, K. | Hamano, T. | Mikami, S. | +9

1
[1]